1.
|
Phase: Phase III Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-1A95, CAN-NCIC-MY8, CLB-E1A95, EORTC-E1A95/06971, SWOG-E1A95, CAN-NCIC-J1A95, CLB-9596, SWOG-S1A95, NCT00002878, E1A95, MY8
|
|
2.
|
Phase: Phase III Type: Treatment Status: Completed Age: 15 to 70 Sponsor: NCI Protocol IDs: E-2995, E2995
|
|
3.
|
Phase: Phase III Type: Treatment Status: Closed Age: 60 and over Sponsor: Other Protocol IDs: LRF-AML14, EU-20016, NCT00005823, ISRCTN62207270
|
|
4.
|
Phase: Phase II, Phase I Type: Treatment Status: Closed Age: 17 and over Sponsor: Protocol IDs: MDA-DM-94052, NCI-V95-0604
|
|
5.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 15 to 59 Sponsor: NCI, Other Protocol IDs: CDR0000065333, U10CA031946, CLB-9621, CALGB-9621, NCT00002925
|
|
6.
|
Phase: Phase II, Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: NCI-97-C-0074C, NCI-T96-0011, T96-0011
|
|
7.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: GOG-126E
|
|
8.
|
Phase: Phase II Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: E-1195, NCT00002826, E1195
|
|
9.
|
Phase: Phase II Type: Treatment Status: Closed Age: over 18 Sponsor: NCI Protocol IDs: MAYO-943001, NCI-V96-1077
|
|
10.
|
Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Completed Age: Not specified Sponsor: NCI, Other Protocol IDs: CDR0000065380, U01CA063265, CHNMC-96002, NCI-H97-1137, NCT00002937
|
|
11.
|
Phase: Phase II Type: Treatment Status: Completed Age: 56 and over Sponsor: NCI, Other Protocol IDs: CDR0000067450, S9918, U10CA032102, SWOG-S9918, NCT00004217
|
|
12.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 to 80 Sponsor: NCI Protocol IDs: NCI-94-C-0119I, NCI-MB-330, NCI-T93-0123N, T93-0123
|
|
13.
|
Phase: Phase I Type: Treatment Status: Completed Age: 60 and over Sponsor: NCI Protocol IDs: CLB-9420, CALGB-9420
|
|
14.
|
Phase: Phase I Type: Treatment Status: Completed Age: over 18 Sponsor: NCI Protocol IDs: WU-95-0718, NCI-T93-0034O, T93-0034
|
|
15.
|
Phase: Phase I Type: Treatment Status: Closed Age: 56 and over Sponsor: NCI Protocol IDs: SWOG-S9617, SWOG-9617, S9617
|
|
16.
|
Phase: Phase I Type: Treatment Status: Completed Age: Under 22 at diagnosis Sponsor: NCI Protocol IDs: POG-9423, CCG-P9423, NCT00002912, P9423
|
|
17.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: MSGCC-9604, NCI-T96-0066, T96-0066
|
|
18.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 and over Sponsor: NCI Protocol IDs: WU-106, NCI-T97-0073, NCT00003207, T97-0073
|
|
19.
|
Phase: Phase I Type: Treatment Status: Completed Age: 18 to 80 Sponsor: NCI Protocol IDs: NCI-92-C-0268K, NCI-T92-0100N, NCI-MB-288
|